Non-specific Response to H1N1 Vaccine

Enhanced Non-Specific T Lymphocytes Response to Influenza A (H1N1) AS03-Adjuvanted Vaccine

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01178918

Enrollment

Registered

2010-08-10

Start date

2009-11-30

Completion date

2012-07-01

Last updated

2020-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza H1N1

Keywords

Influenza H1N1, Vaccine, Adjuvant, T Lymphocytes, Non-specific response, Interleukin-2, Non-specific T cell response

Brief summary

This is a prospective observational study with recruitment of healthy volunteers from consecutive recipients of H1N1 influenza vaccine at the University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia. The purpose of this study is to evaluate certain safety aspects of adjuvanted influenza H1N1 vaccines.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Recipients of H1N1 influenza vaccine. * Healthy individuals with no signs of influenza or other infectious disease.

Exclusion criteria

* Signs of influenza or other infectious disease in 1 month before study participation.

Design outcomes

Primary

Measure	Time frame
T Cell Immune response monitoring after Influenza A (H1N1) AS03-Adjuvanted Vaccination	At 3 weeks after vaccination

Countries

Slovenia

Outcome results